Terlizzi V, Fevola C, Presti S, Castaldo A, et al. Reported Adverse Events in a Multicenter Cohort of Patients Ages 6-18 Years with Cystic Fibrosis and at Least One F508del Allele Receiving Elexacaftor/Tezacaftor/Ivacaftor. J Pediatr 2024;274:114176.
PMID: 38945446